4.6 Article

Measurement of glomerular filtration rate using endogenous D-serine clearance in living kidney transplant donors and recipients

Journal

ECLINICALMEDICINE
Volume 43, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.eclinm.2021.101223

Keywords

D-Serine; Glomerular filtration rate; Kidney transplantation; Creatinine clearance; D-Serine clearance

Funding

  1. Japan Society for the Promotion of Science (JSPS) [17H04188]
  2. Japan Agency of Medical Research and Development (AMED) [JP20gm5010001]
  3. Shiseido Co., Ltd
  4. Osaka Kidney Bank [OKF19-0010]
  5. KAGAMI Inc.
  6. Grants-in-Aid for Scientific Research [17H04188] Funding Source: KAKEN

Ask authors/readers for more resources

This study explored the potential of D-serine clearance as a measure of GFR, showing that D-serine underestimated C-in levels but combining D-serine and creatinine measurements can reduce this bias, providing a more accurate method for GFR measurement.
Background Endogenous molecules that provide an unbiased and a precise evaluation of kidney function are still necessary. We explored the potential of clearance of D-serine, a rare enantiomer of serine and a biomarker of kidney function, as a measure of glomerular filtration rate (GFR). Methods This was a cross-sectional observational study of 200 living kidney transplant donors and recipients enrolled between July 2019 and December 2020 in a single Japanese center, for whom GFR was measured by clearance of inulin (C-in). Clearance of D-serine (C-DSer) was calculated based on blood and urine levels of D-serine, as measured by two-dimensional high-performance liquid chromatography. Analytical performance was assessed by calculating biases. Utilizing data from 129 participants, we developed equations for C-in based on C-DSer and C-cre using a linear regression model, and the performance was validated in 68 participants. Findings The means of C-in and C-DSer were 66.7 and 55.7 mL/min/1.73 m(2) of body surface area, respectively, in the entire cohort. C-DSer underestimated C-in with a proportional bias of 22.0% (95% confidence interval, 14.2-29.8%) and a constant bias of -1.24 (-5.78-3.31), whereas the proportional bias was minor to that of C-cre (34.6% [31.1-38.2%] and 2.47 (-1.18-6.13) for proportional and constant bias, respectively). Combination of C-DSer and C-cre measured C-in with an equation of 0.391 x C-DSer + 0.418 x C-cre + 3.852, which reduced the proportional bias (6.5% [-0.2-13.1%] and -4.30 [-8.87-0.28] for proportional and constant bias, respectively). In the validation dataset, this equation performed well with median absolute residual of 3.5 [2.3-4.8], and high ratio of agreement (ratios of 30% and 15% different from C-in [P-30 and P-15] of 98.5 [91.4-100] and 89.7 [80.0-95.2], respectively). Interpretation The smaller proportional bias compared to that of C-cre is an advantage of C-DSer as a measure of Cin. Combinational measurement of o-serine and creatinine, two endogenous molecules, has the potential to serve as a measure of GFR with precision and minor biases and can support important clinical decisions. Copyright (C) 2021 The Authors. Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available